These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8634415

  • 21. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T.
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [Abstract] [Full Text] [Related]

  • 22. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
    Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C.
    Ann Intern Med; 1995 Feb 01; 122(3):161-8. PubMed ID: 7810932
    [Abstract] [Full Text] [Related]

  • 24. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
    Orito E, Mizokami M, Suzuki K, Ohba KI, Ohno T, Mizuno M, Iijima Y, Saito H, Nemoto A, Nukuta N.
    J Gastroenterol Hepatol; 1997 Jan 01; 12(1):58-61. PubMed ID: 9076625
    [Abstract] [Full Text] [Related]

  • 25. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S.
    Ann Intern Med; 1997 Nov 15; 127(10):875-81. PubMed ID: 9382365
    [Abstract] [Full Text] [Related]

  • 26. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.
    Am J Gastroenterol; 1997 Jan 15; 92(1):73-8. PubMed ID: 8995941
    [Abstract] [Full Text] [Related]

  • 27. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G, Borghesio E, Mesina P, Solinas A, Spezia C, Macor F, Gallo V, Chiandussi L, Donada C, Donadon V, Spirito F, Mangia A, Andriulli A, Verme G, Rizzetto M.
    J Hepatol; 1997 Jul 15; 27(1):56-62. PubMed ID: 9252074
    [Abstract] [Full Text] [Related]

  • 28. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W, Graziadei I, Umlauft F, Datz C, Hackl F, Allinger S, Grünewald K, Patsch J.
    Dig Dis Sci; 1996 Dec 15; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [Abstract] [Full Text] [Related]

  • 29. Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
    Watanabe S, Kobayashi Y, Konishi M, Yokoi M, Kakehashi R, Kaito M, Suzuki S.
    Intern Med; 1993 Jul 15; 32(7):523-9. PubMed ID: 8286827
    [Abstract] [Full Text] [Related]

  • 30. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, Datz C, Judmaier G, Vogel W, Krejs GJ, Gangl A.
    Dig Dis Sci; 1996 Dec 15; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [Abstract] [Full Text] [Related]

  • 31. Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.
    Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L.
    J Med Virol; 1995 Mar 15; 45(3):348-53. PubMed ID: 7775960
    [Abstract] [Full Text] [Related]

  • 32. Detection of hepatitis C viral sequences in formalin-fixed, paraffin-embedded liver tissue: effect of interferon alpha therapy.
    Diamond DA, Davis GL, Qian KP, Lau JY.
    J Med Virol; 1994 Mar 15; 42(3):294-8. PubMed ID: 8006643
    [Abstract] [Full Text] [Related]

  • 33. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
    Weiland O, Zhang YY, Widell A.
    Scand J Infect Dis; 1993 Mar 15; 25(1):25-30. PubMed ID: 8384732
    [Abstract] [Full Text] [Related]

  • 34. Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.
    Yun ZB, Reichard O, Chen M, Lundeberg J, Norkrans G, Fryden A, Sönnerborg A, Weiland O.
    Scand J Infect Dis; 1994 Mar 15; 26(3):263-70. PubMed ID: 7939425
    [Abstract] [Full Text] [Related]

  • 35. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S, Okusa T, Araki A, Fujiki K, Takashimizu I, Okayasu I, Yamamoto N, Sato C.
    J Med Virol; 1995 Jul 15; 46(3):265-8. PubMed ID: 7561801
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D.
    J Med Virol; 1997 Jun 15; 52(2):219-25. PubMed ID: 9179772
    [Abstract] [Full Text] [Related]

  • 37. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L, Izopet J, Moussion F, Alric L, Verdier D, That HT, Duffaut M, Durand D, Puel J, Suc JM.
    Nephrologie; 1997 Jun 15; 18(7):281-6. PubMed ID: 9496568
    [Abstract] [Full Text] [Related]

  • 38. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
    Magrin S, Craxi A, Fabiano C, Marino L, Fiorentino G, Lo Iacono O, Volpes R, Di Marco V, Almasio P, Vaccaro A, Urdea MS, Wilber JC, Bonura C, Gianguzza F, Capursi V, Filiberti S, Stuyver L, Pagliaro L.
    J Hepatol; 1996 Nov 15; 25(5):583-90. PubMed ID: 8938531
    [Abstract] [Full Text] [Related]

  • 39. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
    Shiffman ML, Hofmann CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, Luketic VA, Sanyal AJ, Mills AS, Garrett CT.
    Hepatology; 1997 Sep 15; 26(3):780-5. PubMed ID: 9303513
    [Abstract] [Full Text] [Related]

  • 40. Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.
    Clarysse C, Van den Eynde C, Nevens F, Portier C, Aelbrecht N, Fevery J, Yap SH.
    Neth J Med; 1995 Dec 15; 47(6):265-71. PubMed ID: 8569931
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.